Non-specific cellular proteins

Non-specific cellular proteins refer to a broad and heterogeneous group of proteins that are not the intended primary targets of a drug but may interact with it through non-selective physical or chemical means (Source: IUPAC Compendium of Chemical Terminology). This term is frequently used in pharmacology to describe 'off-target' binding, where promiscuous drugs or highly reactive agents, such as alkylating agents, bind to various cellular components including structural proteins and enzymes (Source: StatPearls, Alkylating Agents). Such interactions are often characterized by low-affinity hydrophobic adsorption or non-specific covalent modification, leading to widespread cellular dysfunction rather than a targeted therapeutic effect (Source: Nature Reviews Drug Discovery, PMID: 25610167). Because these interactions are not localized to a single pathway, they are a major cause of systemic toxicity and adverse drug reactions, often necessitating the monitoring of biomarkers like liver enzymes or creatinine (Source: FDA Guidance for Industry). In drug development, minimizing interaction with non-specific cellular proteins is a critical objective to improve the safety profile and therapeutic index of candidate compounds (Source: Journal of Medicinal Chemistry, PMID: 21417413). Understanding these non-selective interactions is essential for predicting the toxicological profile and pharmacokinetic distribution of medications that lack high molecular specificity.

Other names

Off-target proteinsBystander proteinsNon-specific binding sitesPromiscuous targets

Non-selective covalent adduction, hydrophobic adsorption, or physical denaturation of protein structures (Source: StatPearls).